Search the Newsreel

BRIXMOR PROPERTY GROUP INC : PIPER SANDLER RAISES TARGET PRICE TO $40 FROM $34

Piper Sandler has increased its target price for Brixmor Property Group Inc (BRX.N) to $40 from $34. This update reflects the analyst's revised valuation for the company. The news was reported by Reuters.

Brixmor stock trades steadily as leasing gains support retail-focused REIT

Brixmor Property Group Inc. (BRX) shows a stable retail REIT profile, supported by recent leasing momentum and consistent rent growth. The company focuses on open-air, grocery-anchored shopping centers, which contribute to resilient cash flows and dividend capacity. High occupancy rates and positive leasing spreads …

Brixmor Property Group Is Maintained at Overweight by Piper Sandler

Piper Sandler has reiterated its "Overweight" rating for Brixmor Property Group (BRX). The firm's price target for BRX stock is set at $23.00, indicating an expected upside for the commercial real estate company.

Piper Sandler Issues Positive Forecast for Brixmor Property Group (NYSE:BRX) Stock Price

Piper Sandler has increased its price target for Brixmor Property Group (NYSE:BRX) from $34 to $40, maintaining an "overweight" rating and suggesting a potential upside of 22.77%. Other firms like UBS Group, Truist Financial, and Scotiabank have also issued positive ratings and increased price …

Hsbc Holdings PLC Grows Position in Brixmor Property Group Inc. $BRX

HSBC Holdings PLC significantly increased its stake in Brixmor Property Group Inc. (NYSE:BRX) by 44% in the first quarter, now holding over 1.18 million shares valued at approximately $34.2 million. This move aligns with a broadly positive Wall Street sentiment, as analysts have reiterated …

Brixmor Property Group (BRX) Projected to Post Quarterly Earnings on Monday

Brixmor Property Group (BRX) is projected to report its Q2 2026 earnings after market close on Monday, July 27th, with analysts anticipating earnings of $0.2449 per share and revenue of $354.15 million. The company previously exceeded Q1 estimates, reporting $0.41 EPS and $354.82 million …

Inhibrx Biosciences expands Oxford Finance loan facility to USD 500 million

Inhibrx Biosciences has expanded its loan facility with Oxford Finance to $500 million through a second amendment to their agreement. This expansion includes a new tranche of up to $325 million, with $100 million funded immediately as a Term C Loan and an additional …

Inhibrx Biosciences (Nasdaq: INBX) secures up to $500M Oxford credit

Inhibrx Biosciences has significantly expanded its credit facility with Oxford Finance to an aggregate principal amount of up to $500 million, including an immediate $100 million Term C Loan and potential additional Term D Loans of $225 million. This expansion is outlined in an …

Inhibrx Biosciences Expands Oxford Credit Facility to $500 Million, Draws $100 Million, Issues Warrants

Inhibrx Biosciences expanded its senior secured credit facility with Oxford Finance and other lenders to up to $500 million, immediately drawing $100 million. The company also issued warrants for 21,457 shares to the lenders and pledged its equity in Poplar Therapeutics as collateral. These …

Press Release: Inhibrx Announces Amended Loan Agreement With Oxford Finance, Expanding Total Facility to $500.0 Million

Inhibrx has announced an amended loan agreement with Oxford Finance, increasing its total debt facility from $200.0 million to $500.0 million. This expanded financing is expected to provide greater financial flexibility as Inhibrx approaches potential commercialization for its drug candidates. The agreement also adjusts …

Brixmor Property Group (BRX) Stock After Retail REIT News And Recent Price Pullback

BMO Capital raises Brixmor price target to $37

Brixmor Property: Robust Leasing, Embedded Growth, And Undervalued Stock (NYSE:BRX)

BRIXMOR PROPERTY GROUP ($BRX) Releases Q1 2026 Earnings

Brixmor Property (BRX) Surpasses Q1 FFO and Revenue Estimates

Belararox Limited (ASX:BRX) - Shares, Dividends & News

Belararox Limited (ASX: BRX) - Share Price